ArticleJournal of multidisciplinary healthcare2026
Medical and Psychosocial Challenges Among Patients with Hypoparathyroidism in China: A Cross-Sectional Online Survey.
Article in Journal of multidisciplinary healthcare, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Hypoparathyroidism (HypoPT) is a rare endocrine disorder that is seldom encountered in routine clinical practice, and patient-reported outcomes remain understudied in China. This study aimed to assess patient-perceived medical and psychosocial challenges among people with HypoPT in China. Patients and Methods: In 2025, individuals with HypoPT in China were recruited through the WeChat platform to complete an online, non-probability cross-sectional survey. Collected data covered demographics, self-reported treatment regimens, frequency of treatment adjustment, treatment costs, self-reported symptom burden and complications, impact on work and daily life, the major challenges attributed to HypoPT, unmet treatment needs, and demand for medical resources. Results: A total of 146 respondents participated (104 completed by patients themselves and 42 by family members or guardians with the patient's consent). Over 60% of respondents had had their treatment plans adjusted; 27% reported not taking medications as prescribed, and 34% did not attend follow-up as recommended for diverse reasons. Many respondents reported persistent self-reported symptoms and medical complications, and 47% required care from family members or caregivers. The most prominent self-reported challenges included the need for lifelong medication (61%), significant impairment to physical functions (55%), and physical pain attributed to calcium deficiency and acute episodes (53%). Overall, 79% of respondents desired more effective drugs, and 55% hoped for more insurance/financial support and access to authoritative endocrinologists. Conclusion: Respondents in this online survey reported substantial medical and psychosocial challenges. The findings highlight patient-perceived unmet needs-including more effective therapies, disease education, psychosocial support, and consideration of supportive health policies-and are hypothesis-generating, requiring confirmation in representative, multicenter studies with clinically verified diagnoses and validated patient-reported measures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.